临床儿科杂志 ›› 2015, Vol. 33 ›› Issue (4): 345-.doi: 10.3969 j.issn.1000-3606.2015.04.014

• 综合报道 • 上一篇    下一篇

儿童产超广谱β- 内酰胺酶大肠埃希菌Ⅰ类整合子及其与ESBLs基因关系的研究

蒋鸿超,奎莉越,黄海林,苏敏,樊茂   

  1. 昆明医科大学附属儿童医院检验中心( 江南昆明 650000)
  • 收稿日期:2015-04-15 出版日期:2015-04-15 发布日期:2015-04-15

Class Ⅰ integron and its correlation with genes coding for ESBLs in ESBLs-producing Escherichia coli from children#br#  

 JIANG Hongchao, Kui Liyue, HUANG Hailin, SU Min, FAN Mao   

  1. Department of Clinical Laboratory, Children’s Hospital Affiliated to Kunming Medical University, Kunming 650000,Yunnan, China
  • Received:2015-04-15 Online:2015-04-15 Published:2015-04-15

摘要: 目的 研究儿童产超广谱β-内酰胺酶(ESBLs)大肠埃希菌I类整合子分布及其与ESBLs基因的相关性。方法 采用PCR方法检测100株产ESBLs大肠埃希菌的ESBLs基因,以及100株产ESBLs与100株非产ESBLs大肠埃希菌的I类整合子基因,分析I类整合子与细菌耐药性的关系以及与ESBLs基因的关系。结果 儿科临床产ESBLs大肠埃希菌基因分型以CTX-M型最多见(84.0%),其次为TEM-1型(63.0%);产ESBLs菌株基因分型分布以TEM-1合并CTX-M型最多见(45.0%),其次为CTX-M型(34.0%);产ESBLs和非产ESBLs菌株中I类整合子扩增阳性例数分别是100例(100%)和25例(25%),差异有统计学意义(P<0.05);I类整合子阳性的菌株耐药性明显高于I类整合子阴性的菌株,阳性株对环丙沙星、左氧氟沙星以及氨基糖苷类耐药比率较高,依次为86.4%、88.0%和80.0%。结论 I类整合子在儿科产ESBLs大肠埃希菌中的分布明显高于非产ESBLs菌株,并与产ESBLs菌株耐药性形成高度相关。

Abstract: Objective To study the correlation with Genes Coding for ESBLs and Class Ⅰ Integron in ESBLs-producing Escherichia coli from children. Methods PCR was used for gene typing detection of 100 strains of ESBLs-producing Escherichia coli strains. While detection of class I integrase gene in the 100 strains ESBLs-producing Escherichia coli and 100 strains of non-ESBLs producing Escherichia coli were separately performed by PCR. It provides the solid base not only to reveal the relationship between class I integron and drug resistance, but also the relationship between class I integron and ESBLs-producing. Results The most frequently genotyping from ESBLs-producing Escherichia coli in children is CTX-M (84%), followed by TEM-1 (63%). The predominant distribution of genotype in ESBL- producing strains is TEM-1 + CTX-M (45%), followed by CTX-M (34%). Class I integrase gene detected in ESBLs- producing and non- ESBLs producing strain were 100 cases (100%) and 25 cases (25%) separately, the difference was statistically significant (P<0.05); drug resistance in class I integron positive strains were significantly higher than in class I integron negative strains, especially in Ciprofloxacin, Levofloxacin, and Aminoglycoside (86.4%, 88%, and 80%). Conclusions The distribution of Class I integron in ESBLs-producing Escherichia coli is significantly higher than that in non-ESBLs-producing strains, It is rational that Class I integron highly correlate with strong drug resistance in ESBLs-producing strains.